Icecure Medical (NASDAQ:ICCM) reported quarterly losses of $(0.30) per share which missed the analyst consensus estimate of $(0.29) by 3.45 percent. This is a 6.25 percent increase over losses of $(0.32) per share from the same period last year. The company reported quarterly sales of $3.29 million which missed the analyst consensus estimate of $3.48 million by 5.53 percent. This is a 1.92 percent increase over sales of $3.23 million the same period last year.